United States (National)
Not enough data
Colin Kellaher predominantly covers corporate announcements and financial news, particularly related to mergers and acquisitions, executive appointments, and stock market movements. If you have insights or exclusive information on major corporate deals, significant executive changes within companies, or impactful industry developments in the finance sector, Colin may be interested in your input.
Given his focus on press releases and private sector announcements, pitches should highlight exclusivity or provide a unique angle to grab his attention amidst the flood of standard business news.
This information evolves through artificial intelligence and human feedback. Improve this profile .
PulteGroup top finance executive, Bob O’Shaughnessy, is retiring from the home builder. PulteGroup on Monday said O’Shaughnessy, who joined the Atlanta company as executive vice president and chief financial officer in 2011, will retire at the end of 2025. PulteGroup said Jim Ossowski, currently senior vice president of finance, will succeed O’Shaughnessy as finance chief in February after the final certification of the company’s 2024 financial statements.
Chase has spent more than 12 years at Delta and most recently served as senior vice president of operational finance and a member of the carrier’s leadership committee.
The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.
Humana shares slid more than 20% in premarket trading after the health insurer warned that recent changes in the federal government's quality ratings of certain private Medicare plans could weigh on its profits in 2026.
By: Colin Kellaher
The insurance company tabbed Morgan Stanley veteran Jacques Chappuis to succeed David Hunt at the helm of the Prudential’s $1.4 trillion investment-management business.
AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock sharply lower. Phase 2 studies for emraclidine failed to show a statistically significant improvement in symptoms after six weeks, the biopharmaceutical company said Monday.
By: Colin Kellaher
David Hoffmann said he has held friendly talks with Lee’s management, but that he hasn’t yet made contact with DallasNews.
By: Colin Kellaher
Florida billionaire David Hoffmann aims to create the second-largest newspaper group in America
By: Colin Kellaher
The head of Exxon Mobil’s massive exploration and production arm is retiring after more than three decades with the energy giant and will be replaced by a former General Motors executive.
By: Colin Kellaher
Hershey said Del Pozzo will depart this week, with President and CEO Michele Buck assuming oversight of the business while the Hershey, Pa., company works to identify a successor.
(833) 317-6278 
